IBP Stock +106.23% Since Nov ’07 Pick IBP Stock +106.23% Since Nov ’07 Pick Unlock Top Buy Picks

Range Low Price High Price Comment
30 days $1.24 $2.30 Monday, 15th Apr 2024 ATOS stock ended at $1.71. This is 3.01% more than the trading day before Friday, 12th Apr 2024. During the day the stock fluctuated 6.13% from a day low at $1.63 to a day high of $1.73.
90 days $0.774 $2.30
52 weeks $0.590 $2.30

Historical Atossa Genetics Inc. prices

Date Open High Low Close Volume
2021-03-16 $2.89 $2.90 $2.65 $2.72 7 159 206
2021-03-15 $2.95 $3.06 $2.90 $2.91 5 855 457
2021-03-12 $2.96 $3.13 $2.87 $2.91 11 887 525
2021-03-11 $2.90 $3.60 $2.88 $3.22 46 737 198
2021-03-10 $2.99 $3.09 $2.53 $2.91 26 938 079
2021-03-09 $2.19 $2.54 $2.16 $2.48 8 133 382
2021-03-08 $2.26 $2.29 $2.09 $2.13 6 317 699
2021-03-05 $2.19 $2.34 $1.78 $2.23 12 497 664
2021-03-04 $2.40 $2.47 $2.04 $2.14 11 826 291
2021-03-03 $2.69 $2.73 $2.47 $2.55 8 982 217
2021-03-02 $2.85 $2.92 $2.66 $2.71 5 878 548
2021-03-01 $2.75 $3.12 $2.68 $2.85 17 935 956
2021-02-26 $2.87 $2.90 $2.50 $2.72 11 627 271
2021-02-25 $3.33 $3.36 $2.70 $2.91 22 427 132
2021-02-24 $2.62 $2.86 $2.62 $2.78 6 301 604
2021-02-23 $2.60 $2.78 $2.27 $2.55 13 954 986
2021-02-22 $3.14 $3.20 $2.89 $2.93 11 769 121
2021-02-19 $3.16 $3.33 $3.08 $3.11 7 541 546
2021-02-18 $3.12 $3.26 $3.03 $3.11 9 105 194
2021-02-17 $3.41 $3.42 $3.16 $3.29 12 219 384
2021-02-16 $3.57 $3.62 $3.43 $3.48 10 055 050
2021-02-12 $2.94 $3.78 $2.85 $3.64 31 422 401
2021-02-11 $3.51 $3.51 $3.14 $3.19 18 948 962
2021-02-10 $3.74 $3.75 $3.40 $3.48 20 962 220
2021-02-09 $3.90 $3.91 $3.51 $3.74 18 750 585
Click to get the best stock tips daily for free!

About Atossa Genetics Inc.

Atossa Genetics Atossa Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of medicines in the areas of oncology and infectious diseases. The company's lead program is Endoxifen, an active metabolite of tamoxifen, which is in Phase II clinical trials to treat and prevent breast cancer. It is also developing AT-H201, an inhalation therapy to improve lung function in severely ill and hospitalized COVID-19 patien... ATOS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT